Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium
Cristina Astrid Tentori(Humanitas University), David A. Sallman(Moffitt Cancer Center), Mieke Van Hemelrijck(Ghent University Hospital), P. Brent Ferrell(Vanderbilt University Medical Center), Konstantinos Dimopoulos(Frederiksberg Hospital), Kirsten Grønbæk(University of Copenhagen), Lauren E. Jamieson(King's College Hospital), Aida Santaolalla(King's College London), Dominique Bonnet(The Francis Crick Institute), Charles Manogaran(King's College Hospital), Daniel H. Wiseman(University of Manchester), David Valcárcel(Vall d'Hebron Hospital Universitari), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Xingmin Feng(National Heart Lung and Blood Institute), Sylvie Freeman(University of Birmingham), Theresia M. Westers(Vrije Universiteit Amsterdam), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Bruno A. Cardoso(Universidade Católica Portuguesa), Madeline Hayes(Vanderbilt University), Eric Padron(Moffitt Cancer Center), Austin Kulasekararaj(King's College London), Astrid Marta Olsnes(Haukeland University Hospital), Jonathan M. Irish(Vanderbilt University), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), António Almeida(Hospital da Luz), Emma M. Groarke(MACOM (United States)), Benedetta Tinterri(Ministero della Salute), Sanam Loghavi(The University of Texas MD Anderson Cancer Center), Nicolas Chapuis(Délégation Paris 5), Marco Gabriele Raddi(Azienda Ospedaliero-Universitaria Careggi), Naval Daver(The University of Texas MD Anderson Cancer Center), Nicolas Dulphy(Inserm), Susann Winter(University Hospital Carl Gustav Carus), Katja Sockel(Innsbruck Medical University), Michaëla Fontenay(Université Paris Cité), Vidhya Murthy(NIHR Surgical Reconstruction and Microbiology Research Centre), Laura Gallur(Vall d'Hebron Hospital Universitari), Bhavisha A. Patel(MACOM (United States)), Antonella Poloni(Marche Polytechnic University), Michael Cross(Leeds Teaching Hospitals NHS Trust), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Hugues De Lavellade(Guy's and St Thomas' NHS Foundation Trust), Kathryn E. Strange(King's College London), Benjamin Lim(Imperial College London), Lin P. Zhao(Inserm), Katharina Zoldan(University Hospital Leipzig), Katy Jones(King's College Hospital), Elena Riva(Humanitas University), Wendy Ingram(University Hospital of Wales), Yannick Simoni(Centre National de la Recherche Scientifique)
Cited by 11
Related Papers
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739